AIMC Topic: Drug Discovery

Clear Filters Showing 871 to 880 of 1559 articles

AK-Score: Accurate Protein-Ligand Binding Affinity Prediction Using an Ensemble of 3D-Convolutional Neural Networks.

International journal of molecular sciences
Accurate prediction of the binding affinity of a protein-ligand complex is essential for efficient and successful rational drug design. Therefore, many binding affinity prediction methods have been developed. In recent years, since deep learning tech...

Systematic Data Analysis and Diagnostic Machine Learning Reveal Differences between Compounds with Single- and Multitarget Activity.

Molecular pharmaceutics
Small molecules with multitarget activity are capable of triggering polypharmacological effects and are of high interest in drug discovery. Compared to single-target compounds, promiscuity also affects drug distribution and pharmacodynamics and alter...

REINVENT 2.0: An AI Tool for De Novo Drug Design.

Journal of chemical information and modeling
In the past few years, we have witnessed a renaissance of the field of molecular de novo drug design. The advancements in deep learning and artificial intelligence (AI) have triggered an avalanche of ideas on how to translate such techniques to a var...

Deep Learning Total Energies and Orbital Energies of Large Organic Molecules Using Hybridization of Molecular Fingerprints.

Journal of chemical information and modeling
The ability to predict material properties without the need for resource-consuming experimental efforts can immensely accelerate material and drug discovery. Although ab initio methods can be reliable and accurate in making such predictions, they are...

Profiling SARS-CoV-2 Main Protease (M) Binding to Repurposed Drugs Using Molecular Dynamics Simulations in Classical and Neural Network-Trained Force Fields.

ACS combinatorial science
The current COVID-19 pandemic caused by a novel coronavirus SARS-CoV-2 urgently calls for a working therapeutic. Here, we report a computation-based workflow for efficiently selecting a subset of FDA-approved drugs that can potentially bind to the SA...

Artificial intelligence in drug discovery and development.

Drug discovery today
Artificial intelligence-integrated drug discovery and development has accelerated the growth of the pharmaceutical sector, leading to a revolutionary change in the pharma industry. Here, we discuss areas of integration, tools, and techniques utilized...

Predicting With Confidence: Using Conformal Prediction in Drug Discovery.

Journal of pharmaceutical sciences
One of the challenges with predictive modeling is how to quantify the reliability of the models' predictions on new objects. In this work we give an introduction to conformal prediction, a framework that sits on top of traditional machine learning al...

Machine learning-accelerated quantum mechanics-based atomistic simulations for industrial applications.

Journal of computer-aided molecular design
Atomistic simulations have become an invaluable tool for industrial applications ranging from the optimization of protein-ligand interactions for drug discovery to the design of new materials for energy applications. Here we review recent advances in...

Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery.

Scientific reports
Machine learning is a well-known approach for virtual screening. Recently, deep learning, a machine learning algorithm in artificial neural networks, has been applied to the advancement of precision medicine and drug discovery. In this study, we perf...

Efficient molecular encoders for virtual screening.

Drug discovery today. Technologies
Molecular representations encoding molecular structure information play critical roles in molecular virtual screening (VS). In order to improve VS performance, an abundance of molecular encoders have been developed and tested by various VS challenges...